- R-JET® Technology: one mixer spanning the full platform from R&D to GMP – same design space at every scale.
- QbD-native, modular mixing hardware for different mRNA-LNP formulations with predictable scale-up.
- Enabling personalized mRNA medicine: NANOme® closes the GMP manufacturing gap for mRNA/genome-editing therapies with small batch sizes, a small footprint, fast turnaround, and closed-system aseptic processing.
- Solves scale-up unpredictability: consistent mixing from lab to GMP scale cuts re-optimization and CMC disruption risk – the real cost isn’t lost materials, it’s lost time to process lock, clinical milestones and ultimately product NPV.